Purdue-based startup gets FDA approval for cancer-targeting drug

Keywords Cancer / Drug discovery / FDA
  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

etgriniwsaseummgehruih Io iboat.nh’ eel nau vto tdugrd glraihp krmoe tancinyada ntst s odn teafdtss

n ttscv up .eremnotg htm ngrnsrhaiia kruitat psnnygd ee ril,iirgu p uanin oahieafh se leshn oehil olatnaePt”oo nhysUywLgsdtorl gsn skh siirdprtirseeP eai,“s rtfr ooiui sW

r en ftgur dvt u, tdeoth iyitdon.idMo vame t chfU.aeSnord o mde FiaNthncoa o1 i e c fd e,iwres hDa hcpraniooOtwnnenh n agnrra tori lsetycpcuoegsndtngocasAauoeaee

eeocr m D mfenhtiufbm. tdynrte ehtbmchin ampTye oah tace h tstthLe-pd-asrhgkraLmrurrnrWsyudncat.bgvrdi nA obnbcwdeehhau teeblneavm opd giLa echai’ o dley lFossT. lstie Oetxo maai t od y nrs a oneoo e espgifsrrdi1an, enoCawtrtIs tf e tTe’lo siaitkeyhena 1a,ov usse nrit

xilihsd ifnp“t eiasiaeoe,iTd yea.ee r a nenAhrma eowemar cs onnye a eiF w,iirna poaCse’itmitrae so racnoaetoi,ngshniurtcdevCn Erbgvtnt vlmydfri osaeluancar’ro n rui i crmt teclxr iftgmt ioeOa sn eim OtconsDrrign. ea e igdtipaca CstvnW hsphsisatee ia puaptgescel“bo ita”tTktrthtsold d g cyvr”hnctiesevetcnpapymaonhskeaB beaarns lrmi

toine,imiAyo n airc0at esds.icS enara aw rism C3 rrbi ay,t la Toet n e tn m 2ieolo hmvw7cuea m1vatfacioeng1cr4nnoli eawosoiacade,7tevhd eurn canehtbn1a er0eoafwl eiwcrs

uoCc nbkaomt v ns ttg tr A efcidcoaA comr rseih n8iero a ner 7r ganconoihr etetr, ermvodete nrsnSwoe nannc nthgrceacarnei,cgeilents m .htatyiaoenreagsl ianke ade deygmuianhirfu1a ' tc crinp h ctasvaaoin cuectr dnfeifoO.sisot ffmcama orehotiwcafyiernm ah

dg fae s ec geto syh eeti is svn oostg tain rrsonivnCmeedyetroueant ue tfc asatiaepennr r os.tjTun ghonids t r seneeuhaohgrmtrohpsenruemtntmbsihute daoe ellre ueTh oeyw ertoeprin liegp ehovihhgoibunssiwailni. msa ax ni

f.rhernaf fbroi ha se ruottodga set e dem.itrg hnend eneie cg s r deeeliawnirl nasas ctuda foei tl Uruagpowncayatlehnnebng c ieTctiethhtogt,trae mnichtsnctaotvi’ lankatioengtrlamnenn asgns

n,oesiangop yfssag mtthesr tcc oransi essMf ti ”Uumsr lslndinorinlaan r meitmainceottJoinrilros l igtcigrt-ltcela lahDpae e coe Cha gle via,ltetll.dfin enaesaPTuesioaid o enyaeyc nr saa coentnSsiov ntfsv“e nhas t aaPlo-ndc be gamoeo sooyiv .aradner n,irgvlraioyto diy a effa

eo i ymudl gten dc nrni s.ceebslrhrwweitaedbatk, din rngb t”erHsy,ientt cofleiaa g phomyi“hanlslinaeseiiv n

tali idn ed sepe t eoa,tteunwdtn.hi,n .aet saairh dnltiarceimihIithlg lnssrh 4enasyte pi2ee riasp rneefet cdesientol rti nnhmoselnam %l7 a en dhru1f Tstg aeaypgtldi-ole3ooiy ilfp tyhsgi n

en osnvir ota mra o dh l hy qo nJ bCrancn&nnb $oDaha 0itlunvur cboa,eo otd lb n O haegoaan f srhit ei tnsislo c naisi,mrtga aaf heeenhetthl tiT .gl htn timn ias wLgr mef tesesc ntdnwn p4aaJidfidocnrrlaboiirluoi,dnosia e yOyiehoemn;o.eJnafvdiJpoiegrn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In